Hoe Juve Ajax in 1996 onttroonde en later in opspraak kwam door dopingverdenkingen

In dit artikel:

Juventus won in 1996 the Champions League final against defending champion Ajax in Rome, but the victory was later overshadowed by suspicions of systematic doping within the Italian club. The final ended 1-1 after extra time: Fabrizio Ravanelli scored for Juventus after a mistake by Frank de Boer, while Jari Litmanen equalized for Ajax. In the penalty shootout, Juventus goalkeeper Angelo Peruzzi stopped efforts from Edgar Davids and Sonny Silooy. Vladimir Jugovic then converted the decisive penalty past Edwin van der Sar, making it 4-2 in the shootout and delivering Juventus its first European Cup since 1985.

The triumph was the culmination of a rebuilding process under coach Marcello Lippi. After winning the Italian league and cup in his first season, Lippi strengthened the squad with players including Ciro Ferrara, Didier Deschamps and Jugovic. Juventus finished only second in Serie A in 1995/96, but made a strong European run. After winning its group, the team eliminated Real Madrid and Nantes. Ajax, coached by Louis van Gaal and led by players such as Van der Sar, Litmanen, Patrick Kluivert, Edgar Davids and the De Boer brothers, was considered the favorite and had dominated both Dutch and European football.

Tension was high before the final. Statements from Van Gaal suggesting that the trophy would return to Amsterdam with Ajax’s team contributed to Juventus’s determination. The match remained level after 120 minutes, leaving the title to be decided by penalties. Jugovic appeared remarkably relaxed before his attempt and later said he was convinced that he had been chosen to score the winning goal.

Some Ajax players nevertheless left the stadium with the feeling that something was wrong. Marc Overmars reportedly told Ronald de Boer that one Juventus player looked unnatural, particularly around the eyes, and might have used a substance. De Boer himself initially dismissed the suspicion, assuming that fatigue and differences in physical ability could explain what they had seen.

The issue returned to the foreground in 1998, when AS Roma coach Zdenek Zeman questioned the use of medication in Italian football and specifically raised doubts about the physical performances of Juventus players. Police subsequently searched the club’s offices and training complex, finding 281 different pharmaceutical products. Many were legal medicines, such as painkillers and anti-inflammatory drugs, but prosecutors also investigated whether medication had been administered improperly or to enhance performance.

In the ensuing legal case, hematologist Giuseppe D’Onofrio examined blood data from the Juventus squad. He found unusually large fluctuations in red blood cells and hemoglobin levels, which he said could be explained by blood transfusions or EPO, a hormone that increases red blood-cell production and oxygen transport. According to his assessment, EPO use was almost certain for two players from the mid-1990s and highly probable for seven others. Juventus disputed that probability-based conclusions were sufficient proof.

Club doctor Riccardo Agricola was initially convicted of sports fraud and received a suspended sentence, while general manager Antonio Giraudo was acquitted. Both were acquitted on appeal in 2005. Italy’s highest court later ruled that administering medicines to artificially influence sporting performance could constitute sports fraud, but the relevant prosecution had expired. The acquittals specifically concerning EPO and blood transfusions therefore remained in force. No court ultimately established that Juventus had doped its players in the 1996 final.

In 2013, the Dutch programme Andere Tijden Sport added a new dimension to the controversy. Prosecutor Raffaele Guariniello said that doping samples from Serie A and European matches sent to an official laboratory in Rome had not actually been tested. A former laboratory director confirmed this. A renewed analysis of blood values from the week of the final suggested the use of substances that raised hemoglobin, with EPO presented as one possible explanation. Because the samples had not been properly examined at the time, there was no positive test from the final itself.

The allegations resurfaced when Ajax and Juventus met again in the 2019 Champions League. Former Ajax press officer David Endt described the 1996 opponent as possibly “a little doped,” provoking angry reactions from former Juventus players including Ciro Ferrara and Alessio Tacchinardi. Juventus and its supporters continue to regard the Rome victory as a moment of redemption after the painful 1985 Heysel disaster. For Ajax supporters and others, however, the triumph remains marked by unresolved questions about possible performance-enhancing drug use.